Cargando…
Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review
Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide. HCC is a potential target for cancer surveillance (or screening) as it occurs in well-defined, at-risk populations. Curative therapy is possible only for small tumors and screening strategy has been recommended by the US, Ita...
Autor principal: | Ruggeri, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401970/ https://www.ncbi.nlm.nih.gov/pubmed/22826645 http://dx.doi.org/10.2147/RMHP.S18677 |
Ejemplares similares
-
A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment
por: Yuen, Sydney C., et al.
Publicado: (2021) -
Cost-effectiveness of screening for hepatocellular carcinoma: putting the cart before the horse
por: Braillon, Alain
Publicado: (2012) -
Cost-Effectiveness Analysis of Colorectal Cancer Screening: A Systematic Review
por: Khalili, Farhad, et al.
Publicado: (2020) -
Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis
por: Witjes, Caroline D. M., et al.
Publicado: (2012) -
Screening for Hepatocellular Carcinoma
por: Lui, Hock-Foong
Publicado: (2011)